GLP-1 medications linked to reduced progression of several cancers

Vidcast:  https://www.instagram.com/p/DbOmaiepNmH/Medications originally developed to treat type 2 diabetes and obesity may have another surprising benefit. Cleveland Clinic investigators reporting new findings this week at the national oncology meetings found that patients taking GLP-1 medications—including drugs such as semaglutide—appeared less likely to have several common cancers progress to advanced stages.The study found lower rates of progression in cancers including breast, colorectal, liver, and lung cancer when compared with patients receiving other diabetes medications. While the research does not prove that these drugs prevent or treat cancer, it adds to growing evidence that they may influence how some cancers develop.Researchers emphasize that carefully controlled clinical trials are now needed before these medications can be recommended for cancer treatment. Even so, this is one of the most closely watched areas of medical research today.References for this report are available on my website.#GLP1 #CancerResearch #MedicalResearch #Oncology #Semaglutide